CORC

浏览/检索结果: 共12条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study 期刊论文
TARGETED ONCOLOGY, 2019, 卷号: 14, 期号: 2
作者:  Hong, Xiaonan;  Song, Yuqin;  Huang, Huiqiang;  Bai, Bing;  Zhang, Huilai
收藏  |  浏览/下载:23/0  |  提交时间:2019/12/05
Safety and efficacy of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma from China 会议论文
作者:  Song, Y.;  Hong, X.;  Huang, H.;  Bai, B.;  Zhang, H.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10
作者:  Liu, Peng;  Shi, Yuankai;  Jia, Bo;  Xu, Wei;  Li, Wenyu
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/05
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma 期刊论文
ONCOTARGETS AND THERAPY, 2017, 卷号: 10
作者:  Zhang, Qunling;  Cao, Junning;  Xue, Kai;  Liu, Xiaojian;  Ji, Dongmei
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma 期刊论文
CANCER BIOLOGY & THERAPY, 2017, 卷号: 18, 期号: 4
作者:  Wang, Jing-Wen;  Chen, Jia-Yan;  Lu, Chen;  Tang, Xi
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma 期刊论文
ANNALS OF ONCOLOGY, 2015, 卷号: 26, 期号: 8
作者:  Shi, Y.;  Dong, M.;  Hong, X.;  Zhang, W.;  Feng, J.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma 期刊论文
LEUKEMIA, 2014, 卷号: 28, 期号: 4
作者:  Yan, Z-X;  Wu, L-L;  Xue, K.;  Zhang, Q-L;  Guo, Y.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
NCCN-INTERNATIONALPROGNOSTICINDEX(NCCN-IPI)ISAPOTENTIALPROGNOSTICMODELINPATIENTSWITHPERIPHERALT-CELLLYMPHOMA 会议论文
作者:  Pengpeng Xu;  Wenjiao Qin;  Li Wang;  Bobin Chen;  Yang Shen
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
NCCN-INTERNATIONAL PROGNOSTIC INDEX (NCCN-IPI) IS A POTENTIAL PROGNOSTIC MODEL IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA 会议论文
作者:  Xu, P.;  Qin, W.;  Wang, L.;  Chen, B.;  Shen, Y.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/19
Phase II study of chidamide (CS055), a new subtype-selective oral histone deacetylase inhibitor, in patients with relapsed or refractory peripheral T-cell lymphoma 会议论文
作者:  Shi, Yuan-Kai;  Dong, Mei;  Hong, Xiao-Nan;  Zhang, Wei-Jing;  Feng, Ji-Feng
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace